Drug Screening Market Size 2023 | Share and Industry Forecast 2028 |
Posted: March 23, 2023 |
The latest research study “Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028. Drug screening is the process of analyzing samples of blood, urine, hair, or saliva with immunoassays (IAs) or gas chromatography (GC) with mass spectrometry (MS) to identify the presence of a drug in the body. It is used in numerous settings, such as legal prosecution, risk management, rehabilitation, clinical care, and occupational health. It also helps evaluate patients receiving opioid therapy for adherence and abuse potential. In addition, it aids in the triage of patients with altered mental conditions in rehabilitation. As a result, drug screening finds extensive applications in different medical settings across the globe. Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/drug-screening-market/requestsample Drug Screening Market Trends and Drivers: The global drug screening market is primarily driven by the rising emphasis on creating a safe workplace, as drug abuse can adversely affect employee health, safety, productivity, and morale. Moreover, the increasing number of fatal road accidents has augmented the demand for drug screening to maintain road safety. Additionally, governments of numerous countries are implementing stringent policies to mandate drug screening for military, national security, personnel law enforcement, and public health, which has catalyzed market growth. Furthermore, there has been widespread product usage in sports and athletic competitions to identify performance-enhancing drugs such as steroids and human growth hormone (HGH) in professional athletes. In line with this, the rising participation of individuals in professional sports is another major growth-inducing factor. Besides this, the increasing number of opioid dependency and pain management clinics is contributing to the market growth. Other factors, including the growing incidences of substance abuse and illegal drug use by teenagers and the rising alcohol consumption, are also anticipated to create a favorable market outlook. Global Drug Screening Market 2023-2028 Analysis and Segmentation: Competitive Landscape: The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Drug Screening Companies: Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG and Thermo Fisher Scientific Inc. The report has segmented the market on the basis of region, product and service, sample type and end user. Breakup by Product and Service:
Breakup by Sample Type:
Breakup by End User:
Breakup by Region:
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5624&flag=C If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment. Key highlights of the report:
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization. About Us: IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. Contact Us:
|
||||||||||||||||
|